Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on d4T. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1043646C details a high-yield d4T process avoiding hazardous reagents, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1193021A discloses a scalable method for synthesizing stavudine (d4T) from 5-methyluridine using zinc reductive elimination, offering significant cost reduction and high purity for pharmaceutical manufacturing.